News

ivWatch Names Kathy Cox as Chief Financial Officer

ivWatch, LLC, inventor of the first and only continuous IV infiltration detection technology, appointments Kathy Cox to Chief Financial Officer. With over 23 years of experience, including 15 years in the medical device manufacturing and healthcare markets, Cox will strengthen the ivWatch leadership team and will provide expertise in driving business growth and operational efficiencies. She will lead the Accounting and Finance functions and report directly to President and Chief Executive Officer Gary Warren.

“Kathy is an exciting addition to our leadership team,” said Gary Warren, President and CEO, ivWatch. “Her strength as a leader at several medical device manufacturers and healthcare companies both privately owned and those held by global publicly-traded parent companies will be invaluable as we continue to grow our company, execute against our long-term strategies, and work to deliver breakthrough technologies to hospitals around the globe.”

“I am thrilled to join ivWatch and work alongside a team of inventors that will continue to improve patient safety and care through relentless innovation,” said Kathy Cox. “The company has a proven track record of putting people first to advance IV therapy and I am excited to bring my knowledge and experience throughout my career to help drive the trajectory of ivWatch and fulfill its mission.”

Prior to joining ivWatch, Cox held a series of executive positions for 12 years within Solesis, an operating division of Michelin and Fenner PLC, including Director/General Manager. She also held the role of Finance Director at Charter Medical and at Xeridiem Medical Devices. Over the course of her career, Cox has developed technical expertise in all aspects of corporate finance, financial planning, and accounting. Her Director/General Manager experience provides her with a strategic business view and commercial mindset that assists in communication of financial data across functional areas of a corporation. She specializes in leading transformative change in teams, processes, and systems to support revenue growth.

Cox, an active CPA since 2000, graduated from Florida State University in Tallahassee, Florida with a B.S. in Accounting.

Recent News

01/21/2025

MicroAire Completes Acquisition of NEOSYAD

MicroAire Surgical Instruments, the global leader in power-assisted liposuction, is pleased to announce the acquisition of NEOSYAD, an innovative medical device company that developed a breakthrough technology for adipose tissue engineering. This strategic move reinforces MicroAire’s commitment to advancing medical innovation and strengthening its leadership in the adipose tissue market. NEOSYAD recently received EU MDR

01/17/2025

ATCC Appoints Dr. Ruth Cheng as New President and Chief Executive Officer

ATCC, the world’s premier biological materials management and standards organization, today announced the appointment of Ruth Cheng, PhD, as president and chief executive officer. Dr. Cheng, who has been with ATCC for five years and most recently served as senior vice president and general manager, Research and Industrial Solutions, succeeds Raymond H. Cypess, DVM, PhD, who

01/15/2025

Alliance for Building Better Medicine Partners Secure $3.94 Million Federal Grant to Strengthen Richmond-Petersburg Region’s Pharma and Biotech Workforce and Talent System

Under the leadership of Alliance-member organization J. Sargeant Reynolds Community College (Reynolds), the Alliance for Building Better Medicine has secured a landmark $3.94 million federal grant through the U.S. Economic Development Administration’s (EDA) Good Jobs Challenge Award. The funding will support the Richmond-Petersburg Advanced Pharmaceutical Manufacturing (APM) Workforce Initiative. This transformative project, led by Reynolds